Evidence map›Paper›PMID 42211495›Full record

ArticleFrontiers in oncology2026

Renal clear cell carcinoma with co-existing tumor thrombosis of renal vein and ureter: a case report and review of the literature.

Qingxuan Li, Shuping Sun, Yanchen Wang, Yuxuan Liu, Yaofei Sun

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qingxuan LiSchool of Clinical Medicine, Shandong Second Medical University, Weifang, China.
Shuping SunOncology Department, Laixi People's Hospital, Qingdao, China.
Yanchen WangDepartment of Urology, Weifang People's Hospital, Weifang, Shandong, China.
Yuxuan LiuSchool of Clinical Medicine, Shandong Second Medical University, Weifang, China.
Yaofei SunDepartment of Urology, Weifang People's Hospital, Weifang, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When renal cell carcinoma locally spreads, it usually progresses along the renal vein and inferior vena cava. However, the spread along the ureteral lumen to the bladder is a rare situation. The author has only collected less than 30 similar cases. There is no standard treatment plan for patients with ureteral metastasis at present, and its pathological significance is also unclear. Here, we describe a 56-year-old male patient who presented to our hospital with fever and gross hematuria. After abdominal computed tomography (CT), we diagnosed him with a left renal malignant tumor and thickening of the left renal pelvis and ureter, considering metastasis. Later, cystoscopy was performed, and a ureteral tumor thrombus protruding into the bladder was found under the microscope. Then, laparoscopic radical nephrectomy of the left kidney and transurethral resection of bladder tumor were performed. After the operation, the patient's body temperature significantly decreased, and gross hematuria also improved. The pathology and related immunohistochemistry reported clear cell renal cell carcinoma. The patient has been discharged, and we plan to treat him with axitinib and toripalimab combination therapy as the subsequent treatment plan. This case demonstrates that surgical resection is still an effective treatment option for such cases, and we review the relevant literature and discuss the selection of surgical methods and pathological significance.

Indexed as

radical nephrectomy for renal cancerrenal cancerrenal clear cell carcinomarenal vein tumor thrombusureteral tumor thrombus

Identifiers

PMID42211495
PMCPMC13212044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.